Northwestern Medicine Chicago Proton Center hosts 4th Annual PTCOG-NA Conference in Chicago
(Northwestern Memorial HealthCare) The Northwestern Medicine Chicago Proton Center will host over 200 leading clinicians, physicists and researchers in the growing field of proton therapy at the 4th Annual Particle Therapy Co-Operative Group North-America (PTCOG-NA) Conference, being held Oct. 23-25, 2017 at the Swiss ô tel Chicago. Conference participants will share the latest clinical, scientific and industrial developments in particle beam therapy, an advanced form of radiation therapy using beams of protons to destroy cancer cells and diseased tissue. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 19, 2017 Category: International Medicine & Public Health Source Type: news
IBA, Elekta join forces on software development
Proton therapy firm Ion Beam Applications (IBA) and radiation oncology vendor...Read more on AuntMinnie.comRelated Reading:
IBA posts half-year revenue increases
Elekta adds members to MR-Linac Consortium
Elekta promotes 21 studies at AAPM 2017
Elekta to install Bhutan's 1st linear accelerator
Philips, Varian, IBA partner on Singapore cancer center
IBA inks Va. installation deal (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 25, 2017 Category: Radiology Source Type: news
Elekta inks stereotactic development, software, co-marketing deals
Medical software and equipment company Elekta has signed separate deals with Ion Beam Applications and Brainlab to share and integrate their technologies.
In the memorandum of understanding with Ion Beam Applications, the two companies agreed to collaborate on investment in software development and the sale and marketing of each other’s products through a joint portfolio. Elekta specializes in technological solutions for improving, prolonging and saving the lives of patients with cancer and brain disorders, while IBA develops solutions for the diagnosis and treatment of cancer.
Specifically, the companies plan to focus o...
Source: Mass Device - September 25, 2017 Category: Medical Devices Authors: Alex Beall Tags: Business/Financial News Wall Street Beat Elekta Source Type: news
Mevion files for FDA clearance for S250i proton therapy system
Mevion Medical Systems said yesterday it submitted a 510(k) premarket notification to the FDA for its Mevion S250i proton therapy system with Hyperscan pencil beam scanning tech.
The Mevion S250i features improved pencil beam scanning fields and Hyperscan pencil beam scanning tech to allow for faster energy layer switching, the Littleton, Mass.-based company said.
“We focused on addressing the challenges clinicians faced with 1st generation systems and engineered a novel and transformative solution,” CEO Joseph Jachinowski said in a press release.
The system also features the company’s Adaptive Aperture ...
Source: Mass Device - September 19, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Oncology Regulatory/Compliance Mevion Medical Systems Source Type: news
Mevion submits 510(k) to FDA for proton therapy system
Mevion Medical Systems has submitted a 510(k) premarket notification to the...Read more on AuntMinnie.comRelated Reading:
Mevion touts scanning milestone
Mevion joins forces with MedPhoton
Mevion completes milestone installation
Mevion completes Fla. installation
Mevion, RaySearch partner on info system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 18, 2017 Category: Radiology Source Type: news
MedLever and HKSH collaborate for new MR-guided proton therapy solution
MedLever and the Hong Kong Sanatorium& Hospital (HKSH) have collaborated to develop the information backbone to support the new MR-guided proton therapy solution, which is being developed at the hospital. (Source: Hospital Management)
Source: Hospital Management - September 12, 2017 Category: Hospital Management Source Type: news
Brain imaging can't prove chronic pain
A task force of the International Association for the Study of Pain has concluded...Read more on AuntMinnie.comRelated Reading:
fMRI, EEG may detect consciousness in TBI patients
EEG device could reduce head CT scans
Calif. center to explore proton therapy for pain relief
Diagnosing chronic back pain: More than just looking at images
MR spots reason for chronic groin pain, but may not alter management (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 11, 2017 Category: Radiology Source Type: news
IBA posts half-year revenue increases
Proton therapy firm Ion Beam Applications (IBA) posted revenue increases for...Read more on AuntMinnie.comRelated Reading:
Philips, Varian, IBA partner on Singapore cancer center
IBA inks Va. installation deal
IBA to show updated synthesizer at SNMMI 2017
IBA posts healthy Q1 revenue rise
IBA Molecular forms Curium as new radiopharmacy player (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 24, 2017 Category: Radiology Source Type: news
Belgium ’ s Ion Beam Applications dives on slowing growth
(Reuters) — Belgian proton therapy specialist Ion Beam Applications (EBR:IBAB) lost a third of its $1 billion market value today after it cut its guidance for 2018 and 2019, blaming project delays and increased competition.
The company is a leading maker of machines that deliver cancer-fighting proton beams, a super-precise form of radiation, but it has been beset by delays in the construction of buildings to house its proton therapy systems by third-party contractors.
IBAB shares closed down -35.1% at €20.00 ($23.64) apiece today in Brussels.
“The first half of 2017 has been slower, in line with the customary l...
Source: Mass Device - August 24, 2017 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Radiosurgery Wall Street Beat ionbeamapplications Source Type: news
$1B Hamlin community 1 step closer to getting proton therapy center
The new facility will create about 100 new clinical and administrative jobs. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 21, 2017 Category: Health Management Authors: Veronica Brezina Source Type: news
$1B Hamlin community 1 step closer to getting proton therapy center
The new facility will create about 100 new clinical and administrative jobs. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 21, 2017 Category: Biotechnology Authors: Veronica Brezina Source Type: news
Proton Therapy Insurance Coverage: Fair or Foul? Proton Therapy Insurance Coverage: Fair or Foul?
At one center, the vast majority of requests for coverage for treatment of a set of cancers were approved, although some approvals required going through an appeal process. But was this well done?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 9, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Insurers reverse 97% of pediatric proton denials on appeal
Insurance companies wind up covering proton therapy treatment for pediatric...Read more on AuntMinnie.comRelated Reading:
How to avoid radiology claim denials: Medical necessity
Pediatric proton therapy treatments on the rise (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 8, 2017 Category: Radiology Source Type: news
97 percent of insurance denials in pediatric proton patients overturned on appeal
(University of Pennsylvania School of Medicine) Insurance companies end up covering proton therapy treatment for pediatric cancer patients in 97 percent of the cases they originally deny once those decisions are appealed. Researchers from the Perelman School of Medicine at the University of Pennsylvania analyzed five years of coverage decisions at Penn's Roberts Proton Therapy Center. They discovered that roughly one in 10 pediatric cancer patients are initially denied coverage for the cutting edge and costly treatment - yet nearly all patients ultimately get approval. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 7, 2017 Category: Cancer & Oncology Source Type: news
Concurrent Chemo, Proton Therapy Promising in Advanced Lung Cancer
Five-year results of a single-institution study show that proton beam radiotherapy given concurrently with chemotherapy offers promising clinical outcomes with good toxicity results compared with historical data. (Source: CancerNetwork)
Source: CancerNetwork - August 3, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Lung Cancer News Source Type: news
